OQROSign up free
Politician trade (House)

Danaher Corporation (DHR): Rep. Thomas H. Kean Jr. (NJ07) disclosed a purchase $1K–$15K

Rep. Thomas H. Kean Jr. (NJ07) disclosed a purchase of Danaher Corporation in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
49 days
Disclosure lag
Traded
Jul 31, 2023
Disclosed
Sep 18, 2023

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 25, 2023CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  2. Jul 6, 2023FDARecall: Access Thyroglobulin Calibrators
  3. Jul 31, 2023 · this disclosureCongressDisclosed purchase of DHR — reported range $1,001 - $15,000

What came next

  1. Sep 6, 2023FDARecall: AU/DxC AU Chemistry Transferrin REF: OSR6152 Immune complexes formed in solution scatter light in proportion to their size, shape and concentration. Turbidimet…
  2. Sep 12, 2023FDARecall: DxI 9000 Access Immunoassay Analyzer, REF C11137, Sofware Versions 1.15 and below; invitro diagnostic
  3. Sep 13, 2023CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
  4. Sep 26, 2023CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  5. Oct 19, 2023FDAFDA device clearance: Xpert Xpress MVP; GeneXpert Xpress System
  6. Oct 24, 2023CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  7. Nov 20, 2023FDARecall: Leica HistoCore PEGASUS (PROCESSOR, TISSUE, AUTOMATED)
  8. Nov 21, 2023FDARecall: Access Ultrasensitive Insulin only used on the DxI 9000 Access Immunoassay Analyzer, Catalog Number 33410
  9. Nov 21, 2023FDARecall: DxI 9000 Access Immunoassay Analyzer running software version 1.16 or prior,
  10. Nov 22, 2023FDAFDA device clearance: DxFLEX Flow Cytometer; ClearLLab 10C Panels
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

Other recent filings by Rep. Thomas H. Kean Jr. (NJ07)

The full history of Rep. Thomas H. Kean Jr. (NJ07) is on the profile page.

How this filing works

Explore the data

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data